Business
PAOG Builds CBD "RX" Brand Now Introducing 2nd CBD Product
PAOG Builds CBD "RX" Brand Now Introducing 2nd CBD Product.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG Builds CBD \"RX\" Brand Now Introducing 2nd CBD Product\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG Builds CBD \"RX\" Brand Now Introducing 2nd CBD Product\nPR Newswire\nSANDUSKY, Ohio, Oct. 21, 2021\n\n\n\nSANDUSKY, Ohio, Oct. 21, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under the PAOG CBD \"RX\" brand name.\n\n \n \n \n \n \n \n\n \nRehabRX is a rich formulation with beneficial botanicals proven to support healthy skin. RehabRX is free from any preservatives, colors or flavorings. The CBD comes from hemp grown in the state of Colorado.  It is Gluten-free and Non-GMO.\nPAOG has shipped its first and second CBD nutraceutical products to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ).  Earlier this week, PAOG introduced RelaxRX, a sleep aid. The products will soon be for sale online at www.USMJ.com with additional brick and mortar retail availability to follow.\nPAOG expects revenue to grow rapidly as the company expands its CBD \"RX\" branded line of products. \nLast year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).  PAOG is developing both pharmaceutical and nutraceutical treatments based on this intellectual property.\nLearn more about USMJ's ecommerce site at www.usmj.com.\nLearn more about PAOG at www.paogroupinc.com.\nForward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assura...